Eton Pharmaceuticals Inc. (ETON)
NASDAQ · Healthcare
Eton Pharmaceuticals Inc. Operating Income 2019–2025
Eton Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Eton Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was 2.4 M, a 613.62% decrease year-over-year.
- Eton Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -894000, a 76.31% decrease year-over-year.
- Eton Pharmaceuticals Inc. annual operating income for 2025 was -844000, a 67.50% decrease from 2024.
- Eton Pharmaceuticals Inc. annual operating income for 2024 was -2.6 M, a 117.87% increase from 2023.
- Eton Pharmaceuticals Inc. annual operating income for 2023 was -1.2 M, a 85.57% decrease from 2022.
- Eton Pharmaceuticals Inc. annual operating income for 2022 was -8.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eton Pharmaceuticals Inc. Operating Income — FAQ
Eton Pharmaceuticals Inc. (ETON) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Eton Pharmaceuticals Inc.'s operating income?
Eton Pharmaceuticals Inc. (ETON) reported operating income of -$844,000 for fiscal 2025.
Where can I see ETON's operating income history?
The chart and table above show Eton Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.